Cytozyme Eastern India Pvt Ltd

Cytozyme Eastern India Pvt Ltd - financial services in Kolkata, West Bengal, India. FY 2026 financials & compliance.
CIN U01409WB1980PTC032844 Incorporated 08 July 1980 ROC Kolkata HQ Kolkata, West Bengal, India
Active Private Limited Company financial services
Data last updated
Revenue · FY 2025
₹8.18 Lakh
▲ 23% YoY
Net profit · FY 2025
₹5.56 Lakh
Net margin 67.9%
EBITDA · FY 2025
₹7.15 Lakh
EBITDA margin 87.4%
Authorised capital
₹3.5 Cr
Registered with MCA
Paid-up capital
₹2.87 Cr
Issued & subscribed
Company age
46 yrs
Est. 1980
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Cytozyme Eastern India Pvt Ltd

Data last updated:

Cytozyme Eastern India Pvt Ltd is a private limited company based in Kolkata, West Bengal, India. It operates in the diversified financial services segment of the financial services sector. It was incorporated on 08 July 1980 and has been in existence for over 46 years.

The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U01409WB1980PTC032844.

The company has an authorised share capital of ₹3.5 Cr and a paid-up capital of ₹2.87 Cr. It is led by directors Sheo Shankar Pandey and Ravi Shankar Pandey.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 19 Synagogue Street City Centre Room No – 417, Kolkata, West Bengal, India – 700001.

As per the financials filed for FY 2025, the company reported a revenue of ₹8.18 Lakh, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹5.56 Lakh (net margin 67.9%) and EBITDA of ₹7.15 Lakh (EBITDA margin 87.4%). Revenue has declined at a compounded annual rate (CAGR) of 104% over three years and 17% over five years.

Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it. The company has 5 deals on record (3 secondary share transfers, 2 funding rounds), with disclosed funding of ₹13.68 Cr; the latest was in July 2013. Its 7 peer companies in the BFSI industry (Other Financial Services), with the same principal business activity (other financial activities) are compared by revenue, 4 larger and 3 smaller; the largest is Udeta Logipark Private Limited with revenue of ₹8.2 Lakh.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U01409WB1980PTC032844
Registration Number 032844
Incorporation Date 08 July 1980
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Cytozyme Eastern India Pvt Ltd's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    19 Synagogue Street City Centre Room No – 417, Kolkata, West Bengal, India – 700001
  • Industry
    Financial Services, Diversified Financial Services

To see the full contact details of Cytozyme Eastern India Pvt Ltd, buy the company report.

Comprehensive company report
Cytozyme Eastern India Pvt Ltd - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Cytozyme Eastern India Pvt Ltd

FY 2025 filings available

Cytozyme Eastern India Pvt Ltd reported revenue of ₹8.18 Lakh (up 23% YoY) for FY 2025.

Revenue · FY 2025
₹8.18 Lakh ▲ 23%
Net profit · FY 2025
₹5.56 Lakh margin 67.9%
EBITDA · FY 2025
₹7.15 Lakh margin 87.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 23%
3 years · compounded
▲ 104%
5 years · compounded
▼ 17%
EBITDA CAGR growth
1 year
▲ 18%
3 years · compounded
▲ 60%
5 years · compounded
▼ 7%

Revenue rose 23% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 17%. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹7.15 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹5.56 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin87.4%
Net Profit Margin67.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Cytozyme Eastern India Pvt Ltd, buy the company report.

Board of directors of Cytozyme Eastern India Pvt Ltd

Cytozyme Eastern India has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sheo Shankar PandeyDirector03 Dec 201312 Years 10 MonthsCurrent
Ravi Shankar PandeyDirector15 Dec 201015 Years 10 MonthsCurrent

Peer comparison

Cytozyme Eastern India Pvt Ltd is compared with the 7 companies closest to it by revenue in the BFSI industry (Other Financial Services), with the same principal business activity (other financial activities), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Udeta Logipark Private Limited₹8.2 Lakh (FY 2025)505.0%Kolkata, West Bengal, India
Intelligent Credit Consultants Private Limited₹8.19 Lakh (FY 2025)0.0%Delhi, India
Billionbs Securities Trade Centre Private Limited₹8.19 Lakh (FY 2023)-77.0%Irinjalakuda, Kerala, India
Hari Krishan Coated Sheets Limited₹8.19 Lakh (FY 2024)3.0%Uttar Pradesh, India
Cytozyme Eastern India Pvt Ltdthis company₹8.18 Lakh (FY 2025)₹5.56 Lakh67.9%23.0%Kolkata, West Bengal, India
Sujay Fiscal Pvt.Ltd.₹8.18 Lakh (FY 2024)-19.0%Kolkata, West Bengal, India
Trigunatmika Trading and Properties Ltd₹8.18 Lakh (FY 2025)523.0%Delhi, India
Mataji Promoter Private Limited₹8.17 Lakh (FY 2025)Kolkata, West Bengal, India

To see the full peer comparison of Cytozyme Eastern India Pvt Ltd, buy the company report.

Auditor

Cytozyme Eastern India Pvt Ltd is audited by K S A & CO for the financial year 2019.

Auditor firmFinancial yearFirm registration number
K S A & COFY 2019003822C

Shareholding

The shareholding of Cytozyme Eastern India Pvt Ltd is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Cytozyme Eastern India Pvt Ltd, buy the company report.

Deals & funding

Cytozyme Eastern India Pvt Ltd has 5 deals on record (3 secondary share transfers, 2 funding rounds), with disclosed funding of ₹13.68 Cr; the latest was in July 2013.

Total deals
5
Secondary share transfers
3
Funding rounds
2
Disclosed funding
₹13.68 Cr

Deals on record (5 of 5)

WhenDealAmountParties
Jul 2013Secondary share transferUndisclosedBuyer: Garima Mercantiles Private Limited , Shashank Exports Private Limited , Onward Finvest Private Limited
Seller: Udhyaman Investments Private Limited , Pet Properties and Constructions Private Limited
Mar 2012Funding round₹7.43 CrInvestors: Vishwamitra India Finvest Services Limited , Nexus Barter Private Limited , Swarnarekha Dealcom Private Limited
Aug 2011Secondary share transferUndisclosedBuyer: Srishti Tracom Private Limited , Onward Finvest Private Limited , Chetali Viniyog Private Limited
Seller: 3 individuals
Mar 2011Funding round₹6.26 CrInvestors: Udhyaman Investments Private Limited , Harsharatna Finance and Investments Private Limited , Pet Properties and Constructions Private Limited
Mar 2006Secondary share transferUndisclosedBuyer: an individual
Seller: 3 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Cytozyme Eastern India Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Cytozyme Eastern India Pvt Ltd; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Cytozyme Eastern India Pvt Ltd has 7 board changes on record since 2009: 2 appointments and 5 cessations. The latest: Sheo Shankar Pandey ceased to be Additional Director on 30 Sep 2014.

AGM
Cytozyme Eastern India Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Cytozyme Eastern India Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata I.
Ceased
Sheo Shankar Pandey ceased to be Additional Director.
Ceased
Sanjay Kumar Pandit ceased to be Director.
Appointed
Sheo Shankar Pandey was appointed as Director.
Ceased
Asis Kumar Bhattacharhee ceased to be Director.
Ceased
Rabin Kumar Bose ceased to be Director.
Appointed
Ravi Shankar Pandey was appointed as Director.
Ceased
Vithal Das Mall ceased to be Director.
Incorporation
08 Jul 1980
Cytozyme Eastern India Pvt Ltd was registered on 08 Jul 1980 with Roc Kolkata I & aged 46 years 3 months as per MCA records.

Frequently asked questions

Cytozyme Eastern India is an active private limited company based in Kolkata, West Bengal, India. The company works in diversified financial services, within the financial services industry. It was incorporated on 08 July 1980 (46+ years old) and is registered under CIN U01409WB1980PTC032844.

Cytozyme Eastern India has 2 current directors:

The latest financial statements of Cytozyme Eastern India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Cytozyme Eastern India is U01409WB1980PTC032844. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Cytozyme Eastern India has 3 court cases on record: 2 filed by the company and 1 filed against it. Most are in the high courts.

Cytozyme Eastern India was incorporated on 08 July 1980, making it 46+ years old. It is registered with the Registrar of Companies, Kolkata.

Cytozyme Eastern India has 5 deals on record (3 secondary share transfers, 2 funding rounds), with disclosed funding of ₹13.68 Cr; the latest was in July 2013.

The peers of Cytozyme Eastern India by revenue are Udeta Logipark Private Limited, Intelligent Credit Consultants Private Limited, Billionbs Securities Trade Centre Private Limited, Hari Krishan Coated Sheets Limited, Sujay Fiscal Pvt.Ltd. and 2 more, all in the BFSI industry (Other Financial Services), with the same principal business activity (other financial activities).

Sheo Shankar Pandey ceased to be Additional Director on 30 Sep 2014. Sanjay Kumar Pandit ceased to be Director on 03 Dec 2013. Sheo Shankar Pandey was appointed as Director on 03 Dec 2013. Cytozyme Eastern India has 7 board changes on record in total.

The registered office of Cytozyme Eastern India is at 19 Synagogue Street City Centre Room No – 417, Kolkata, West Bengal, India – 700001.

Cytozyme Eastern India operates in the financial services industry, in the diversified financial services segment.